Tracey McCain
Responsabile della Conformità presso BLUEPRINT MEDICINES CORPORATION
Patrimonio netto: 6 M $ in data 30/04/2024
Posizioni attive di Tracey McCain
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| BLUEPRINT MEDICINES CORPORATION | Responsabile della Conformità | 06/09/2016 | - |
| Consigliere Generale | 06/09/2016 | - | |
| Segretario Aziendale | 06/09/2016 | - | |
| KINIKSA PHARMACEUTICALS, LTD. | Direttore/Membro del Consiglio | 01/02/2018 | - |
| Independent Dir/Board Member | 01/02/2018 | - |
Storia della carriera di Tracey McCain
Precedenti posizioni note di Tracey McCain
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| IMMUNOGEN, INC. | Direttore/Membro del Consiglio | 15/11/2021 | 12/02/2024 |
| Independent Dir/Board Member | 15/11/2021 | 12/02/2024 | |
Genzyme Therapeutics Ltd.
 Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | Consigliere Generale | 01/01/2016 | 02/09/2016 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Consigliere Generale | 01/05/1997 | 01/09/2016 |
| Palmer & Dodge LLP | Corporate Officer/Principal | - | - |
Formazione di Tracey McCain
| University of Pennsylvania | Undergraduate Degree |
| Columbia Law School | Graduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 8 |
| Regno Unito | 2 |
Posizioni
| General Counsel | 3 |
| Director/Board Member | 2 |
| Independent Dir/Board Member | 2 |
Settori
| Health Technology | 6 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| BLUEPRINT MEDICINES CORPORATION | Health Technology |
| KINIKSA PHARMACEUTICALS, LTD. | Health Technology |
| Aziende private | 4 |
|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
| Palmer & Dodge LLP | Commercial Services |
ImmunoGen, Inc.
 ImmunoGen, Inc. BiotechnologyHealth Technology ImmunoGen, Inc. engages in the discovery and development of antibody-drug conjugates to improve outcomes for cancer patients. Its pipeline includes Mirvetuximab Soravtansine, IMGN632, IMGC936, and IMGN151. The company was founded on March 27, 1981 and is headquartered in Waltham, MA. | Health Technology |
Genzyme Therapeutics Ltd.
Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | Health Technology |
- Borsa valori
- Insiders
- Tracey McCain
- Esperienza
